| 1FKN | A:; B: | STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR |
| 1M4H | A:; B: | CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR OM00-3 |
| 1SGZ | A:; B:; C:; D: | CRYSTAL STRUCTURE OF UNBOUND BETA-SECRETASE CATALYTIC DOMAIN. |
| 1TQF | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR |
| 1W50 | A: | APO STRUCTURE OF BACE (BETA SECRETASE) |
| 1W51 | A: | BACE (BETA SECRETASE) IN COMPLEX WITH A NANOMOLAR NON-PEPTIDIC INHIBITOR |
| 1XN2 | A:; B:; C:; D: | NEW SUBSTRATE BINDING POCKETS FOR BETA-SECRETASE. |
| 1XN3 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONG INHIBITOR WITH ADDITIONAL UPSTREAM RESIDUES. |
| 1XS7 | D: | CRYSTAL STRUCTURE OF A CYCLOAMIDE-URETHANE-DERIVED NOVEL INHIBITOR BOUND TO HUMAN BRAIN MEMAPSIN 2 (BETA-SECRETASE). |
| 2B8L | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR |
| 2B8V | A: | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH L-L000430,469 |
| 2F3E | A:; B:; C: | CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH AXQ093, A MACROCYCLIC INHIBITOR |
| 2F3F | A:; B:; C: | CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH BDF488, A MACROCYCLIC INHIBITOR |
| 2FDP | A:; B:; C: | CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH AN AMINO-ETHYLENE INHIBITOR |
| 2G94 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A POTENT AND HIGHLY SELECTIVE INHIBITOR. |
| 2HIZ | A:61P-385; B:61P-385; C:61P-385 | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR |
| 2HM1 | A: | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR (2) |
| 2IQG | A: | CRYSTAL STRUCTURE OF HYDROXYETHYL SECONDARY AMINE-BASED PEPTIDOMIMETIC INHIBITOR OF HUMAN BETA-SECRETASE (BACE) |
| 2IRZ | A: | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR |
| 2IS0 | A: | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR |
| 2NTR | A: | CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO INHIBITOR |
| 2OAH | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR |
| 2OF0 | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 5 |
| 2OHK | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 1-AMINO-ISOQUINOLINE |
| 2OHL | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 2-AMINOQUINOLINE |
| 2OHM | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH N~3~-BENZYLPYRIDINE-2,3-DIAMINE |
| 2OHN | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 4-(4-FLUOROBENZYL)PIPERIDINE |
| 2OHP | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 3 |
| 2OHQ | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 4 |
| 2OHR | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6A |
| 2OHS | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6B |
| 2OHT | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 7 |
| 2OHU | A: | X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8B |
| 2P4J | A:; B:; C:; D: | CRYSTAL STRUCTURE OF BETA-SECRETASE BOND TO AN INHIBITOR WITH ISOPHTHALAMIDE DERIVATIVES AT P2-P3 |
| 2P83 | A:61P-385; B:61P-385; C:61P-385 | POTENT AND SELECTIVE ISOPHTHALAMIDE S2 HYDROXYETHYLAMINE INHIBITOR OF BACE1 |
| 2P8H | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR |
| 2PH6 | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR |
| 2PH8 | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR |
| 2Q11 | A:; B:; C: | STRUCTURE OF BACE COMPLEXED TO COMPOUND 1 |
| 2Q15 | A: | STRUCTURE OF BACE COMPLEXED TO COMPOUND 3A |
| 2QK5 | A:; B: | STRUCTURE OF BACE1 BOUND TO SCH626485 |
| 2QMD | A:; B: | STRUCTURE OF BACE BOUND TO SCH722924 |
| 2QMF | A:; B: | STRUCTURE OF BACE BOUND TO SCH735310 |
| 2QMG | A:; B: | STRUCTURE OF BACE BOUND TO SCH745966 |
| 2QP8 | A:; B: | STRUCTURE OF BACE BOUND TO SCH734723 |
| 2QU2 | A: | BACE1 WITH COMPOUND 1 |
| 2QU3 | A: | BACE1 WITH COMPOUND 2 |
| 2QZK | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH I21 |
| 2QZL | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH IXS |
| 2VKM | A:; B:; C:; D: | CRYSTAL STRUCTURE OF GRL-8234 BOUND TO BACE (BETA-SECRETASE) |
| 2ZDZ | A: | X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 3.B.10 |
| 2ZE1 | A: | X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 6G |
| 2ZHR | A:; B: | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH OM99-2 AT PH 5.0 |
| 2ZHS | A: | CRYSTAL STRUCTURE OF BACE1 AT PH 4.0 |
| 2ZHT | A: | CRYSTAL STRUCTURE OF BACE1 AT PH 4.5 |
| 2ZHU | A: | CRYSTAL STRUCTURE OF BACE1 AT PH 5.0 |
| 2ZHV | A: | CRYSTAL STRUCTURE OF BACE1 AT PH 7.0 |
| 2ZJH | A: | CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-(1-BENZYL-PIPERIDIN-4-YL)-4-MERCAPTO-BUTYRAMIDE |
| 2ZJI | A: | CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(2,6-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE |
| 2ZJJ | A: | CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(4-FLUORO-BENZYL)-PIPERAZINE-2-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE |
| 2ZJK | A:; B:; C: | CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(4-FLUORO-BENZYL)-PIPERAZINE-2-CARBOXYLIC ACID(3-MERCAPTO-PROPYL)-AMIDE |
| 2ZJL | A: | CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-BROMO-2,3-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE |
| 2ZJM | A: | CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(4-SULFAMOYL-PHENOXY)-ACETAMIDE |
| 2ZJN | A: | CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(2-METHYL-4-SULFAMOYL-PHENOXY)-ACETAMIDE |
| 3CIB | A:; B: | STRUCTURE OF BACE BOUND TO SCH727596 |
| 3CIC | A:; B: | STRUCTURE OF BACE BOUND TO SCH709583 |
| 3CID | A:; B: | STRUCTURE OF BACE BOUND TO SCH726222 |
| 3DUY | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-AFJ144 |
| 3DV1 | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-ARV999 |
| 3DV5 | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-BAV544 |
| 3EXO | A: | CRYSTAL STRUCTURE OF BACE1 BOUND TO INHIBITOR |
| 3FKT | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH SPIROPIPERDINE IMINOHYDANTOIN INHIBITOR |
| 3HVG | A:; B:; C: | STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH EV0 |
| 3HW1 | A:; B:; C: | STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH LIGAND EV2 |
| 3I25 | A:; B:; C: | POTENT BETA-SECRETASE 1 HYDROXYETHYLENE INHIBITOR |
| 3IGB | A: | BACE-1 WITH COMPOUND 3 |
| 3IN3 | A: | BACE1 WITH COMPOUND 30 |
| 3IN4 | A: | BACE1 WITH COMPOUND 38 |
| 3IND | A: | BACE1 WITH THE AMINOHYDANTOIN COMPOUND 29 |
| 3INE | A: | BACE1 WITH THE AMINOHYDANTOIN COMPOUND S-34 |
| 3INF | A: | BACE1 WITH THE AMINOHYDANTOIN COMPOUND 37 |
| 3INH | A: | BACE1 WITH THE AMINOHYDANTOIN COMPOUND R-58 |
| 3IVH | A: | DESIGN AND SYNTHESIS OF POTENT BACE-1 INHIBITORS WITH CELLULAR ACTIVITY: STRUCTURE-ACTIVITY RELATIONSHIP OF P1 SUBSTITUENTS |
| 3IVI | A:; B:; C: | DESIGN AND SYNTHESIS OF POTENT BACE-1 INHIBITORS WITH CELLULAR ACTIVITY: STRUCTURE-ACTIVITY RELATIONSHIP OF P1 SUBSTITUENTS |
| 3IXJ | A:; B:; C: | CRYSTAL STRUCTURE OF BETA-SECRETASE 1 IN COMPLEX WITH SELECTIVE BETA-SECRETASE 1 INHIBITOR |
| 3IXK | A:; B:; C: | POTENT BETA-SECRETASE 1 INHIBITOR |
| 3K5C | A:; B:; C: | HUMAN BACE-1 COMPLEX WITH NB-216 |
| 3K5D | A:; B:; C: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH AHM178 |
| 3K5F | A:; B:; C: | HUMAN BACE-1 COMPLEX WITH AYH011 |
| 3K5G | A:; B:; C: | HUMAN BACE-1 COMPLEX WITH BJC060 |
| 3KMX | A:; B: | STRUCTURE OF BACE BOUND TO SCH346572 |
| 3KMY | A:; B: | STRUCTURE OF BACE BOUND TO SCH12472 |
| 3KN0 | A:; B: | STRUCTURE OF BACE BOUND TO SCH708236 |
| 3KYR | A:; B:; C: | BACE-1 IN COMPLEX WITH A NORSTATINE TYPE INHIBITOR |
| 3L38 | A: | BACE1 IN COMPLEX WITH THE AMINOPYRIDINE COMPOUND 44 |
| 3L3A | A: | BACE-1 WITH THE AMINOPYRIDINE COMPOUND 32 |
| 3L58 | A:; B: | STRUCTURE OF BACE BOUND TO SCH589432 |
| 3L59 | A:; B: | STRUCTURE OF BACE BOUND TO SCH710413 |
| 3L5B | A:; B: | STRUCTURE OF BACE BOUND TO SCH713601 |
| 3L5C | A:; B: | STRUCTURE OF BACE BOUND TO SCH723871 |
| 3L5D | A:; B: | STRUCTURE OF BACE BOUND TO SCH723873 |
| 3L5E | A:; B: | STRUCTURE OF BACE BOUND TO SCH736062 |
| 3L5F | A:; B: | STRUCTURE OF BACE BOUND TO SCH736201 |
| 3LHG | A: | BACE1 IN COMPLEX WITH THE AMINOHYDANTOIN COMPOUND 4G |
| 3LNK | A:; B: | STRUCTURE OF BACE BOUND TO SCH743813 |
| 3MSJ | A:; B:; C: | STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH INHIBITOR |
| 3MSK | A: | FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS |
| 3MSL | A: | FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS |
| 3N4L | A:; B:; C: | BACE-1 IN COMPLEX WITH ELN380842 |
| 3NSH | A:; B:; C: | BACE-1 IN COMPLEX WITH ELN475957 |
| 3OOZ | A: | BACE1 IN COMPLEX WITH THE AMINOHYDANTOIN COMPOUND 102 |
| 3PI5 | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH BFG356 |
| 3QBH | A:; B:; C: | STRUCTURE BASED DESIGN, SYNTHESIS AND SAR OF CYCLIC HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS |
| 3QI1 | A: | DESIGN AND SYNTHESIS OF HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS: PRIME SIDE CHROMANE-CONTAINING INHIBITORS |
| 3R1G | B: | STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY |
| 3RSV | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH (R)-3-(2-AMINO-6-O-TOLYLQUINOLIN-3-YL)-N-((R)-2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-YL)-2-METHYLPROPANAMIDE |
| 3RSX | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 6-(THIOPHEN-3-YL)QUINOLIN-2-AMINE |
| 3RTH | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 6-(2-(3,3-DIMETHYLBUT-1-YNYL)PHENYL)QUINOLIN-2-AMINE |
| 3RTM | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINOQUINOLIN-3-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE |
| 3RTN | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINO-6-O-TOLYLQUINOLIN-3-YL)-N-CYCLOHEXYLPROPANAMIDE |
| 3RU1 | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINOQUINOLIN-3-YL)-N-(CYCLOHEXYLMETHYL)PROPANAMIDE |
| 3RVI | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 2-((2-AMINO-6-O-TOLYLQUINOLIN-3-YL)METHYL)-N-(CYCLOHEXYLMETHYL)PENTANAMIDE |
| 3S2O | A: | FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS |
| 3S7L | A: | PYRAZOLYL AND THIENYL AMINOHYDANTOINS AS POTENT BACE1 INHIBITORS |
| 3S7M | A: | PYRAZOLYL AND THIENYL AMINOHYDANTOINS AS POTENT BACE1 INHIBITORS |
| 3TPJ | A: | APO STRUCTURE OF BACE1 |
| 3TPP | A: | CRYSTAL STRUCTURE OF BACE1 COMPLEXED WITH AN INHIBITOR |
| 3TPR | A: | CRYSTAL STRUCTURE OF BACE1 COMPLEXED WITH AN INHIBITOR |
| 3U6A | A:; B:; C: | RATIONAL DESIGN AND SYNTHESIS OF AMINOPIPERAZINONES AS BETA SECRETASE (BACE) INHIBITORS |
| 3UDH | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 1 |
| 3UDJ | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 5 |
| 3UDK | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 6 |
| 3UDM | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 8 |
| 3UDN | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 9 |
| 3UDP | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 12 |
| 3UDQ | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 13 |
| 3UDR | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 14 |
| 3UDY | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 11 |
| 3UFL | A: | DISCOVERY OF PYRROLIDINE-BASED B-SECRETASE INHIBITORS: LEAD ADVANCEMENT THROUGH CONFORMATIONAL DESIGN FOR MAINTENANCE OF LIGAND BINDING EFFICIENCY |
| 3UQU | A: | CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR |
| 3UQW | A: | CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR |
| 3UQX | A: | CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR |
| 3VEU | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-AVI326 |
| 3VF3 | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BQQ711 |
| 3VG1 | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BUR436, DERIVED FROM A SOAKING EXPERIMENT |
| 3VV6 | A: | CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3-METHYL-6-((1S, 2R)-2-PHENYLCYCLOPROPYL)PYRIMIDIN-4(3H)-ONE |
| 3VV7 | A: | CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-6-((1S,2R)-2-(3'-METHOXYBIPHENYL-3-YL)CYCLOPROPYL)-3-METHYLPYRIMIDIN-4(3H)-ONE |
| 3VV8 | A: | CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3-METHYL-6-((1S,2R)-2-(3'-METHYLBIPHENYL-4-YL)CYCLOPROPYL)PYRIMIDIN-4(3H)-ONE |
| 3WB4 | A: | CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3,6-DIMETHYL-6-(2-PHENYLETHYL)-3,4,5,6-TETRAHYDROPYRIMIDIN-4-ONE |
| 3WB5 | A: | CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH (6S)-2-AMINO-3,6-DIMETHYL-6-[(1R,2R)-2-PHENYLCYCLOPROPYL]-3,4,5,6-TETRAHYDROPYRIMIDIN-4-ONE |
| 4ACU | A: | AMINOIMIDAZOLES AS BACE-1 INHIBITORS. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 14 |
| 4ACX | A: | AMINOIMIDAZOLES AS BACE-1 INHIBITORS. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 23 |
| 4AZY | A: | DESIGN AND SYNTHESIS OF BACE1 INHIBITORS WITH IN VIVO BRAIN REDUCTION OF BETA-AMYLOID PEPTIDES (COMPOUND 10) |
| 4B00 | A: | DESIGN AND SYNTHESIS OF BACE1 INHIBITORS WITH IN VIVO BRAIN REDUCTION OF BETA-AMYLOID PEPTIDES (COMPOUND (R)-41) |
| 4B05 | A: | PRECLINICAL CHARACTERIZATION OF AZD3839, A NOVEL CLINICAL CANDIDATE BACE1 INHIBITOR FOR THE TREATMENT OF ALZHEIMER DISEASE |
| 4B0Q | A: | LEAD GENERATION OF BACE1 INHIBITORS BY COUPLING NON-AMIDINE NEW WARHEADS TO A KNOWN BINDING SCAFFOLD |
| 4B1D | A: | NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB-LOWERING IN BRAIN |
| 4B1E | A: | NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB-LOWERING IN BRAIN |
| 4B70 | A: | AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN |
| 4B72 | A: | AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN |
| 4B77 | A: | AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN |
| 4B78 | A: | AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN |
| 4D83 | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BUR436, DERIVED FROM A CO-CRYSTALLIZATION EXPERIMENT |
| 4D85 | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BVI151 |
| 4D88 | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXQ490 |
| 4D89 | A: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXD552, DERIVED FROM A SOAKING EXPERIMENT |
| 4D8C | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXD552, DERIVED FROM A CO-CRYSTALLIZATION EXPERIMENT |
| 4DH6 | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH (2R)-N-((2S,3R)-1-(BENZO[D][1,3]DIOXOL-5-YL)-3-HYDROXY-4-((S)-6'-NEOPENTYL-3',4'-DIHYDROSPIRO[CYCLOBUTANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YLAMINO) BUTAN-2-YL)-2-METHOXYPROPANAMIDE |
| 4DI2 | A:; B:; C: | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE INHIBITOR 37 |
| 4DJU | A:; B: | STRUCTURE OF BACE BOUND TO 2-IMINO-3-METHYL-5,5-DIPHENYLIMIDAZOLIDIN-4-ONE |
| 4DJV | A:; B: | STRUCTURE OF BACE BOUND TO 2-IMINO-5-(3'-METHOXY-[1,1'-BIPHENYL]-3-YL)-3-METHYL-5-PHENYLIMIDAZOLIDIN-4-ONE |
| 4DJW | A:; B: | STRUCTURE OF BACE BOUND TO 2-IMINO-3-METHYL-5-PHENYL-5-(3-(PYRIDIN-3-YL)PHENYL)IMIDAZOLIDIN-4-ONE |
| 4DJX | A:; B: | STRUCTURE OF BACE BOUND TO 5-(3-(5-CHLOROPYRIDIN-3-YL)PHENYL)-5-CYCLOPROPYL-2-IMINO-3-METHYLIMIDAZOLIDIN-4-ONE |
| 4DJY | A:; B: | STRUCTURE OF BACE BOUND TO (R)-5-CYCLOPROPYL-2-IMINO-3-METHYL-5-(3-(5-(PROP-1-YN-1-YL)PYRIDIN-3-YL)PHENYL)IMIDAZOLIDIN-4-ONE |
| 4DPF | A: | BACE-1 IN COMPLEX WITH A HEA-MACROCYCLIC TYPE INHIBITOR |
| 4DPI | A: | BACE-1 IN COMPLEX WITH HEA-MACROCYCLIC INHIBITOR, MV078512 |
| 4DUS | A: | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH N-((2S,3R)-1-(4-FLUOROPHENYL)-3-HYDROXY-4-((6'-NEOPENTYL-3',4'-DIHYDROSPIRO[CYCLOBUTANE-1,2'-PYRANO[2,3-B]PYRIDIN]-4'-YL)AMINO) BUTAN-2-YL)ACETAMIDE |
| 4EWO | A: | DESIGN AND SYNTHESIS OF POTENT HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS |
| 4EXG | A: | DESIGN AND SYNTHESIS OF POTENT HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS |
| 4FCO | A: | CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR |
| 4FM7 | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 14G |
| 4FM8 | A: | CRYSTAL STRUCTURE OF BACE WITH COMPOUND 12A |
| 4FRI | A: | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH BIARYLSPIRO AMINOOXAZOLINE 6 |
| 4FRJ | A: | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH AMINOOXAZOLINE XANTHENE 9L |
| 4FRK | A: | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH AMINOOXAZOLINE XANTHENE 11A |
| 4FRS | A:; B: | STRUCTURE OF BACE IN COMPLEX WITH (S)-4-(3-CHLORO-5-(5-(PROP-1-YN-1-YL)PYRIDIN-3-YL)THIOPHEN-2-YL)-1,4-DIMETHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM |
| 4FS4 | A:; B: | STRUCTURE OF BACE BOUND TO (S)-4-(3'-METHOXY-[1,1'-BIPHENYL]-3-YL)-1, 4-DIMETHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM |
| 4FSL | A:; B:; D:; E: | CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-DB-MUT) COMPLEX WITH N-(N-(4- ACETAMIDO-3-CHLORO-5-METHYLBENZYL) CARBAMIMIDOYL)-3-(4- METHOXYPHENYL)-5-METHYL-4-ISOTHIAZOLECARBOXAMIDE |
| 4GID | A:; B:; C:; D: | STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR |
| 4GMI | A: | BACE-1 IN COMPLEX WITH HEA-TYPE MACROCYCLIC INHIBITOR, MV078571 |
| 4H1E | A:; B: | STRUCTURE OF BACE-1 BOUND TO (7AR)-6-BENZOYL-7A-(4-(3-CYANOPHENYL) THIOPHEN-2-YL)-3-METHYL-4-OXOHEXAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-2(3H)-IMINIUM |
| 4H3F | A:; B: | STRUCTURE OF BACE BOUND TO 3-(5-((7AR)-2-IMINO-6-(6-METHOXYPYRIDIN-2-YL)-3-METHYL-4-OXOOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL) THIOPHEN-3-YL)BENZONITRILE |
| 4H3G | A:; B: | STRUCTURE OF BACE BOUND TO 2-((7AR)-7A-(4-(3-CYANOPHENYL)THIOPHEN-2-YL)-2-IMINO-3-METHYL-4-OXOHEXAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-6(2H)-YL)NICOTINONITRILE |
| 4H3I | A:; B: | STRUCTURE OF BACE BOUND TO 3-(5-((7AR)-2-IMINO-6-(3-METHOXYPYRIDIN-2-YL)-3-METHYL-4-OXOOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL) THIOPHEN-3-YL)BENZONITRILE |
| 4H3J | A:; B: | STRUCTURE OF BACE BOUND TO 2-FLUORO-5-(5-(2-IMINO-3-METHYL-4-OXO-6-PHENYLOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL)THIOPHEN-2-YL) BENZONITRILE |
| 4HA5 | A:; B: | STRUCTURE OF BACE BOUND TO (S)-3-(5-(2-IMINO-1,4-DIMETHYL-6-OXOHEXAHYDROPYRIMIDIN-4-YL)THIOPHEN-3-YL)BENZONITRILE |
| 4HZT | A: | STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES |
| 4I0D | A: | DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS |
| 4I0E | A: | DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS |
| 4I0F | A: | DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS |
| 4I0G | A: | DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS |
| 4I0H | A:; B:; C: | SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS. |
| 4I0I | A:; B:; C: | SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS |
| 4I0J | A: | SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS |
| 4I0Z | A: | STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES |
| 4I10 | A: | STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES |
| 4I11 | A: | STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES. |
| 4I12 | A: | DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS |
| 4I1C | A: | DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS |
| 4IVS | A: | CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR |
| 4IVT | A: | CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR |
| 4J0P | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J0T | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-ETHOXY-PYRIDINE-2-CARBOXYLIC ACID [3-((R)-2-AMINO-5,5-DIFLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J0V | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R)-2-AMINO-5-FLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J0Y | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5S)-2-AMINO-5-FLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J0Z | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,5R)-2-AMINO-5-FLUORO-4-FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J17 | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-4-DIFLUOROMETHYL-5,6-DIHYDRO-4H-[1, 3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J1C | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-5,5-DIFLUORO-4-FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J1E | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6S)-2-AMINO-4-FLUOROMETHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J1F | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6S)-2-AMINO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J1H | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6R)-2-AMINO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J1I | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R,6R)-2-AMINO-5-FLUORO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4J1K | A: | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R,6S)-2-AMINO-5-FLUORO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE |
| 4JP9 | A: | SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS |
| 4JPC | A: | SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS |
| 4JPE | A: | SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS |
| 4K8S | A:; B:; C: | HYDROXYETHYLAMINE-BASED INHIBITORS OF BACE1: P1-P3 MACROCYCLIZATION CAN IMPROVE POTENCY, SELECTIVITY, AND CELL ACTIVITY |
| 4K9H | A:; B:; C: | BACE-1 INHIBITOR COMPLEX |
| 4KE0 | A:; B:; C: | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE-MACROCYCLIC INHIBITOR 13 |
| 4KE1 | A: | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE-MACROCYCLIC INHIBITOR 19 |
| 4L7G | A: | DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE1) |
| 4L7H | A: | DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE-1) |
| 4L7J | A: | DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE-1) |
| 4LC7 | A: | AMINOOXAZOLINE INHIBITOR OF BACE-1 |
| 4LXA | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 11A |
| 4LXK | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 11D |
| 4LXM | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 12A |
)
)